News

Entrectinib is a new, orally available, selective tyrosine kinase inhibitor and is designed as a targeted therapeutic candidate to treat patients with cancers that harbor activating alterations to

As part of the deal, Hapten received a one-time upfront cash payment of $100,000 and 200,000 shares of RXi common stock. Hapten will also be eligible to receive

Nocdurna (desmopressin orally disintegrating tablets) is an antidiuretic that contains desmopressin, a structural analogue of the natural pituitary hormone arginine vasopressin. The drug works by stimulating vasopressin receptors

The data show that topical application of AKP-11 was safe, well-tolerated as well as resulted in a significant reduction in plaque severity. The company said that no detectable

Cytune is focused on researching and developing new therapies for immune modulation aimed to improve immune response of patients suffering from cancer and infectious diseases. PPF Group shareholder

"In mid-2013 we announced that we had received notification that our patent and trademarks for the Nyloxin® line of pain relievers had been published in India’s Official Journal,

The agreement will strengthen AstraZeneca’s aclidinium respiratory franchise and is expected to add immediate revenues with long-term growth potential. Upon completion of the transaction, AstraZeneca will own the

Valued at $90 per Hospira share, the acquisition is expected to improve Pfizer’s Global Established Pharmaceutical (GEP) Business as well as strengthen its portfolio of generic injectable drugs

The patented cotton enhanced insulating materials used in all the packaging products offer soft cushioning thermal protection. The packaging, post-use, is disposable by the customer as ordinary household